.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Abstractvortrag
VS-13-4

A Randomised Open-Label Trial of Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19 as model of early treatment in a pandemia with a new pathogen: Experience from collection of very high-titer plasma from superimmunized individuals

Appointment

Date: 22/09/2022

Time: 14:00 – 14:10

Talk time: 6 Min.

Discussion time: 4 Min.

Location / Stream:

Gustav Mahler 3.1

Session

Topics

1. Blutspende und Donormanagement
19. COVID-19

Authors

Prof. Dr. med. Bernd Jahrsdörfer (Ulm / DE), Simone Hoffmann (Ulm / DE), Dr. Matthias Johnsen (Dresden / DE), Dr. med Thomas Burkhardt (Plauen / DE), Dr. med Youhai Li (Ulm / DE), Dr. med. Henrike Hofmann (Ulm / DE), Carolin Ludwig (Ulm / DE), Christiane Vieweg (Ulm / DE), Christina Krämer (Ulm / DE), Dr. Rebecca Müller (Mannheim / DE), Dr. Thomas Appl (Ulm / DE), Prof. Erhard Seifried (Frankfurt a. M. / DE), Dr. med. Sixten Körper (Ulm / DE), Prof. Hubert Schrezenmeier (Ulm / DE)